60 Degrees Pharmaceuticals SXTP Q4 2025 Annual earnings
Reported March 26, 2026 · Before market open
Revenue$300.0KMiss by $20.0K
EPS-$1.91Beat by $0.37
Revenue estimate$320.0K
EPS estimate-$2.28
Next report
Aug 12, 2026 (In 2 weeks)Revenue estimate$185.0K
EPS estimate-$0.74
Versus estimates
Revenue
Diluted EPS
Ask the moment 60 Degrees Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did 60 Degrees Pharmaceuticals report Q4 2025 earnings?
- 60 Degrees Pharmaceuticals (SXTP) reported Q4 2025 earnings on March 26, 2026 before market open.
- What were 60 Degrees Pharmaceuticals's Q4 2025 revenue and EPS?
- 60 Degrees Pharmaceuticals reported revenue of $300.0K and eps of $-1.91 for Q4 2025.
- Did 60 Degrees Pharmaceuticals beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $320.0K by $20.0K. EPS beat the consensus estimate of $-2.28 by $0.37.
- How did 60 Degrees Pharmaceuticals's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 14.7% from $261.4K a year earlier and eps grew 86.5% from $-14.20.
- Where can I find 60 Degrees Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001554855-26-000467) directly on SEC EDGAR. The filing index links above go to sec.gov.